i-SENS, Inc. (099190.KQ)
KRW 16060.0
(-3.37%)
KRW 16060.0
(-3.37%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 45.74 Billion KRW | -28.16% |
| 2022 | 63.68 Billion KRW | -32.42% |
| 2021 | 94.23 Billion KRW | 120.11% |
| 2020 | 42.81 Billion KRW | 114.79% |
| 2019 | 19.93 Billion KRW | -42.09% |
| 2018 | 34.42 Billion KRW | -9.12% |
| 2017 | 37.87 Billion KRW | 64.63% |
| 2016 | 23 Billion KRW | -9.13% |
| 2015 | 25.31 Billion KRW | -9.37% |
| 2014 | 27.93 Billion KRW | 30.42% |
| 2013 | 21.41 Billion KRW | 137.91% |
| 2012 | 9 Billion KRW | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 79.75 Billion KRW | 77.32% |
| 2024 Q1 | 47.86 Billion KRW | -1.69% |
| 2023 Q4 | 45.74 Billion KRW | -47.17% |
| 2023 Q1 | 63.78 Billion KRW | 0.16% |
| 2023 Q2 | 63.13 Billion KRW | -1.02% |
| 2023 FY | 45.74 Billion KRW | -28.16% |
| 2023 Q3 | 86.59 Billion KRW | 37.16% |
| 2022 FY | 63.68 Billion KRW | -32.42% |
| 2022 Q1 | 93.99 Billion KRW | -0.25% |
| 2022 Q3 | 79.49 Billion KRW | -16.96% |
| 2022 Q4 | 63.68 Billion KRW | -19.89% |
| 2022 Q2 | 95.72 Billion KRW | 1.84% |
| 2021 FY | 94.23 Billion KRW | 120.11% |
| 2021 Q1 | 42.18 Billion KRW | -5.43% |
| 2021 Q2 | 41.03 Billion KRW | -2.73% |
| 2021 Q4 | 94.23 Billion KRW | 132.8% |
| 2021 Q3 | 40.47 Billion KRW | -1.36% |
| 2020 Q1 | 19.82 Billion KRW | -3.74% |
| 2020 Q3 | 37.51 Billion KRW | 102.8% |
| 2020 FY | 42.81 Billion KRW | 114.79% |
| 2020 Q4 | 44.6 Billion KRW | 18.9% |
| 2020 Q2 | 18.49 Billion KRW | -6.7% |
| 2019 Q1 | 34.4 Billion KRW | -0.04% |
| 2019 FY | 19.93 Billion KRW | -42.09% |
| 2019 Q3 | 23.98 Billion KRW | -28.77% |
| 2019 Q2 | 33.66 Billion KRW | -2.15% |
| 2019 Q4 | 20.59 Billion KRW | -14.1% |
| 2018 Q4 | 34.42 Billion KRW | -2.98% |
| 2018 Q1 | 36.81 Billion KRW | -2.8% |
| 2018 Q2 | 36.55 Billion KRW | -0.71% |
| 2018 FY | 34.42 Billion KRW | -9.12% |
| 2018 Q3 | 35.47 Billion KRW | -2.94% |
| 2017 Q4 | 37.87 Billion KRW | 17.93% |
| 2017 Q3 | 32.11 Billion KRW | -2.74% |
| 2017 Q1 | 20.76 Billion KRW | -9.75% |
| 2017 FY | 37.87 Billion KRW | 64.63% |
| 2017 Q2 | 33.02 Billion KRW | 59.04% |
| 2016 Q3 | 22.28 Billion KRW | -6.74% |
| 2016 FY | 23 Billion KRW | -9.13% |
| 2016 Q4 | 23 Billion KRW | 3.23% |
| 2016 Q2 | 23.89 Billion KRW | -3.2% |
| 2016 Q1 | 24.68 Billion KRW | -2.5% |
| 2015 Q2 | 26.78 Billion KRW | -3.36% |
| 2015 FY | 25.31 Billion KRW | -9.37% |
| 2015 Q1 | 27.71 Billion KRW | -0.79% |
| 2015 Q4 | 25.31 Billion KRW | -0.87% |
| 2015 Q3 | 25.54 Billion KRW | -4.63% |
| 2014 Q3 | 20.66 Billion KRW | -2.16% |
| 2014 FY | 27.93 Billion KRW | 30.42% |
| 2014 Q2 | 21.12 Billion KRW | -2.28% |
| 2014 Q4 | 27.93 Billion KRW | 35.16% |
| 2014 Q1 | 21.61 Billion KRW | 0.93% |
| 2013 Q1 | 7.33 Billion KRW | -18.55% |
| 2013 Q3 | 6.12 Billion KRW | -11.06% |
| 2013 Q4 | 21.41 Billion KRW | 249.69% |
| 2013 Q2 | 6.88 Billion KRW | -6.08% |
| 2013 FY | 21.41 Billion KRW | 137.91% |
| 2012 FY | 9 Billion KRW | 0.0% |
| 2012 Q4 | 9 Billion KRW | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Osang Healthcare Co.,Ltd | 367.49 Million KRW | -12349.131% |
| InBody Co.,Ltd | 3.63 Billion KRW | -1158.174% |
| Curexo Inc. | 1.48 Billion KRW | -2974.259% |
| Seegene, Inc. | 1.42 Billion KRW | -3114.027% |
| Ray Co., Ltd. | 155.4 Million KRW | -29339.725% |
| Gencurix Inc. | 5.47 Billion KRW | -735.441% |
| Sugentech Inc. | 240 Million KRW | -18962.222% |
| L&C Bio Co., Ltd | 541.32 Million KRW | -8351.44% |